Saluda Medical Announces First U.S. Surgical Cases Using Newly Approved CAP24™ Paddle Lead
BLOOMINGTON, Minn., July 16, 2026 /PRNewswire/ -- Saluda Medical, Inc. (ASX: SLD, "Saluda" or the "Company"), a commercial‑stage medical device company advancing closed‑loop neuromodulation for chronic neurological conditions, today announced the first U.S. surgical cases using the newly...
BLOOMINGTON, Minn., July 16, 2026 /PRNewswire/ -- Saluda Medical, Inc. (ASX: SLD, "Saluda" or the "Company"), a commercial‑stage medical device company advancing closed‑loop neuromodulation for chronic neurological conditions, today announced the first U.S. surgical cases using the newly...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.